Enzolytics Inc (ENZC)

[foxi]

Notes on Series B Shares and Conversions

If the SAGA deal goes through with SEC approval, Gaurav Chandra, Charles Cotropia, Joseph Cotropia, Suraj Saggar, and Kirsten Bischof would all have new roles under SAGA, per this PR. Assumedly Harry would continue his role in VIRO, which is also being sold to SAGA. (More notes.)

Would these insiders have any capacity to also continue work for ENZC? Would they have any remaining meaningful stake in ENZC? Would they try to cash out their ENZC holdings?


https://www.otcmarkets.com/otcapi/company/financial-report/387028/content

If you add up insiders' Series B shares from the 2023 Third Quarterly (Page 28) you get 388,880,000 Series B shares.

Series B shares have Conversion Rights and can be converted 1:10 at any time into ENZC Common Stock. So the insiders transitioning to SAGA hold Series B worth a potential total of 3,888,800,000 ENZC Common Stock. Keep in mind there are 11 Series B shareholders of record according to Page 4, and I see various Bulgarian names purchasing and converting Series B in the tables on Page 10.

Assumedly the Bulgarians and IMMB who have purchased Series B would have invested for the technologies now moving to SAGA.

There's currently 727,022,643 shares of headroom in ENZC Common Stock, and four other Convertible Preferred classes, Warrants, and Convertible Promissory Notes which haven't been evaluated here.

Be wary.